Total Payments
$5,161
2024 Payments
$373.52
Companies
33
Transactions
277
Medicare Patients
500
Medicare Billing
$84,810
Payment Breakdown by Category
Food & Beverage$5,154 (99.9%)
Education$7.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,154 | 276 | 99.9% |
| Education | $7.12 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $736.32 | 40 | $0 (2024) |
| Merck Sharp & Dohme LLC | $546.04 | 29 | $0 (2022) |
| Amgen Inc. | $499.39 | 26 | $0 (2024) |
| AbbVie Inc. | $440.93 | 23 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $372.35 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $265.73 | 15 | $0 (2021) |
| GlaxoSmithKline, LLC. | $238.06 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $236.78 | 8 | $0 (2024) |
| Allergan, Inc. | $207.87 | 11 | $0 (2020) |
| Novo Nordisk Inc | $192.71 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $373.52 | 17 | AstraZeneca Pharmaceuticals LP ($85.22) |
| 2023 | $281.16 | 13 | GlaxoSmithKline, LLC. ($130.94) |
| 2022 | $539.41 | 26 | Bayer HealthCare Pharmaceuticals Inc. ($220.37) |
| 2021 | $885.85 | 43 | AbbVie Inc. ($173.88) |
| 2020 | $868.49 | 44 | Allergan, Inc. ($175.08) |
| 2019 | $554.12 | 30 | AstraZeneca Pharmaceuticals LP ($153.21) |
| 2018 | $977.76 | 63 | AstraZeneca Pharmaceuticals LP ($176.77) |
| 2017 | $681.06 | 41 | Novartis Pharmaceuticals Corporation ($142.85) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 5 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/02/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/17/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Bone Health | ||||||
| 10/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: DIABETES | ||||||
| 10/20/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/13/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/06/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, BELSOMRA | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/01/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Bone Health | ||||||
| 08/25/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/11/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 100 | 166 | $27,730 | $18,978 |
| 2022 | 5 | 138 | 217 | $31,140 | $19,833 |
| 2021 | 5 | 130 | 253 | $35,850 | $23,087 |
| 2020 | 4 | 132 | 262 | $36,665 | $22,912 |
Total Patients
500
Total Services
898
Medicare Billing
$84,810
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 135 | $21,685 | $14,627 | 67.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $6,045 | $4,351 | 72.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 75 | 142 | $22,720 | $14,571 | 64.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $5,460 | $4,043 | 74.1% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2022 | 13 | 23 | $2,300 | $573.00 | 24.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 11 | 12 | $360.00 | $350.74 | 97.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 12 | $300.00 | $295.00 | 98.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 78 | 183 | $29,280 | $19,702 | 67.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $2,535 | $1,906 | 75.2% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2021 | 16 | 34 | $3,400 | $926.64 | 27.3% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 12 | 12 | $360.00 | $340.44 | 94.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $275.00 | $211.09 | 76.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 87 | 213 | $34,080 | $21,766 | 63.9% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 17 | 17 | $510.00 | $469.33 | 92.0% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2020 | 13 | 17 | $1,700 | $392.98 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 15 | $375.00 | $284.02 | 75.7% |
About Dr. Brian Minkus, D.O
Dr. Brian Minkus, D.O is a Family Medicine healthcare provider based in Artesia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235165507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Minkus, D.O has received a total of $5,161 in payments from pharmaceutical and medical device companies, with $373.52 received in 2024. These payments were reported across 277 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,154).
As a Medicare-enrolled provider, Minkus has provided services to 500 Medicare beneficiaries, totaling 898 services with total Medicare billing of $84,810. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Artesia, CA
- Active Since 06/25/2006
- Last Updated 10/20/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235165507
Products in Payments
- FARXIGA (Drug) $655.03
- ENTRESTO (Drug) $355.31
- JANUVIA (Drug) $333.70
- EVENITY (Biological) $268.98
- VRAYLAR (Drug) $260.98
- Kerendia (Drug) $236.78
- Vascepa (Drug) $185.38
- XARELTO (Drug) $176.61
- Androgel (Drug) $175.39
- Otezla (Drug) $136.03
- TRELEGY ELLIPTA (Drug) $126.98
- UBRELVY (Drug) $120.77
- BELSOMRA (Drug) $119.19
- AREXVY (Drug) $111.08
- Tymlos (Biological) $108.45
- HETLIOZ (Drug) $100.77
- Trintellix (Drug) $97.12
- JARDIANCE (Drug) $96.97
- Ozempic (Drug) $95.08
- MYRBETRIQ (Drug) $90.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Artesia
Dr. Peter Jewell, M.d, M.D
Family Medicine — Payments: $2,816
Family Medicine $2,816
Joe Salgado, Md, MD
Family Medicine — Payments: $122.22
Family Medicine $122.22
Dr. Maria Carmelita Go, Md, MD
Family Medicine — Payments: $113.78
Family Medicine $113.78
Lisa Yearwood, M.d, M.D
Family Medicine — Payments: $66.86
Family Medicine $66.86
Jorge Abalos, Do, DO
Family Medicine — Payments: $17.50
Family Medicine $17.50
Michael Grafe, D.o, D.O
Family Medicine
Family Medicine